Clopidogrel Bisulfate Patent Expiration
Clopidogrel Bisulfate was first introduced by Sanofi Aventis Us Llc
Clopidogrel Bisulfate Patents
Given below is the list of patents protecting Clopidogrel Bisulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Plavix |
US6429210 (Pediatric) | Polymorphic clopidogrel hydrogenesulphate form |
Dec 10, 2019
(Expired) | Sanofi Aventis Us |
| Plavix |
US6504030 (Pediatric) | Polymorphic form of clopidogrel hydrogen sulphate |
Dec 10, 2019
(Expired) | Sanofi Aventis Us |
| Plavix | US6429210 | Polymorphic clopidogrel hydrogenesulphate form |
Jun 10, 2019
(Expired) | Sanofi Aventis Us |
| Plavix | US6504030 | Polymorphic form of clopidogrel hydrogen sulphate |
Jun 10, 2019
(Expired) | Sanofi Aventis Us |
Clopidogrel Bisulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List